Radiopharmaceuticals are an emerging medical technology that deliver radiation therapy directly to cancer cells while sparing the rest of the body from the harsh effects of cancer treatment.
13 September 2022
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
20 October 2021
